Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. The company is headquartered in Chengdu, Sichuan and currently employs 268 full-time employees. The company went IPO on 2016-03-10. The firm mainly operates its businesses through three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion and channel management activities for the sales of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research, development and manufacture of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services. The firm mainly conducts its business in the domestic market.
06833.HK stock price ended at $0.16 on 金曜日, after dropping 11.11%
On the latest trading day Feb 13, 2026, the stock price of 06833.HK fell by 11.11%, dropping from $0.16 to $0.16. During the session, the stock saw a volatility of 6.25%, with prices oscillating between a daily low of $0.16 and a high of $0.17. On the latest trading day, the trading volume for 06833.HK rose by 856.0K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 856.0K shares were traded, with a market value of approximately $325.2M.